Table 2

Outcomes of 17 T and Tk antigen activated infants compared with outcomes of 28 weight and gestation matched controls who developed NEC after September 1991

VariableT/Tk antigen activated infants (%)Matched control infants (%)Odds ratios (95% confidence intervals)p Value
Number of infants1728
Died6 (35%)2 (7%)7.1 (1.2, 40.8)0.04*
Surgery for NEC11 (65%)14 (50%)1.8 (0.5, 6.3)0.37 NS
Haemolysis on blood film12 (71%)6 (21%)8.8 (2.2, 35.0)0.002*
Bilirubin ⩾250 μmol/l with NEC3 (18%)1 (4%)5.8 (0.5, 60.9)0.14 NS
Exchange transfusion1 (6%)0 (0%)5.2 (0.2, 134.8)0.38 NS
Hyperkalaemia (K+⩾6.5 mmol/l)8 (47%)1 (4%)24 (2.6, 219.2)0.0008*
Haematuria (UA ⩾ 3+)7 (41%)1 (4%)18.9 (2.1, 173.7)0.003*
Anuria6 (35%)1 (4%)14.7 (1.6, 137.1)0.008*
Maximum creatinine (SD) (μmol/l)104.6 (42.6)74.4 (29.2)0.02*
Hypotension treated with inotropes12 (71%)11 (39%)3.7 (1.0, 13.5)0.07 NS
Acidosis treated with bicarbonate6 (35%)2 (7%)7.1 (1.2, 40.8)0.04*
Colloid required (SD) (ml/kg)69 (35)31 (23)0.0005*
Blood transfusions (SD) (ml/kg)48 (33)42 (28)0.52 NS
Mean lowest platelet count (×109/l) (SD)152 (139)228 (177)0.14 NS
Platelet transfusion given7 (41%)5 (18%)3.2 (0.8, 12.6)0.16 NS
Leucopenia (white cells <5.0 × 109/l)9 (53%)9 (32%)2.4 (0.7, 8.2)0.22 NS
Positive blood culture6 (35%)6 (21%)2.0 (0.5, 7.7)0.32 NS
  • CI, confidence interval; * significant, p<0.05.